Takeda, Advinus initiate three-year discovery collaboration

Takeda, Advinus to initiate three-year discovery collaboration

6:46 AM, 8th October 2012
Takeda, Advinus to initiate three-year discovery collaboration
Dr Rashmi Barbhaiya, Chief Executive Officer, Advinus.

MUMBAI, INDIA: Takeda Pharmaceutical Company Ltd and Advinus Therapeutics Ltd have entered into an agreement to initiate a three-year discovery collaboration focused on novel targets for major therapeutic areas including inflammation, CNS, and metabolic diseases. In this collaboration, Advinus is responsible for leading the programme to create optimal IND ready compounds for pre-defined targets.

Takeda will receive worldwide commercial rights to drug candidates emerging from this alliance. Advinus will receive guaranteed research funding of $36 million over the term of the collaboration, $9 million in milestones leading to candidate selection, and is eligible to receive future clinical and regulatory milestone payments of up to $45 million per product, plus royalties on product sales worldwide.

“Advinus team is delighted that its biggest ever collaboration has been made possible by Takeda’s visionary leadership, and their confidence in the founding principles that aim to create these new R&D opportunities. Takeda and Advinus teams together will advance globally networked innovation for addressing key Pharma R&D issue – R&D productivity for better return on R&D investments,” said Dr Rashmi Barbhaiya, Chief Executive Officer, Advinus.

© WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Tessenderlo to invest in water treatment chemicals in France

BRUSSELS, BELGIUM: Tessenderlo Group has launched a turnaround project to reposition its Loos, France site to focus on the production of water treatme ...

Read more
Versalis, Honam JV for elastomer production in South Korea

MILAN, ITALY: Versalis, Eni’s chemical subsidiary and global leader in elastomers, and Honam Petrochemical Corporation, one of the major petroch ...

Read more
BASF, Purac JV for biobased succinic acid production

LUDWIGSHAFEN, GERMANY/DIEMEN, THE NETHERLANDS: BASF and Purac, a subsidiary of CSM, are establishing a joint venture for the production and sale of bi ...

Read more
Dr Reddy’s launches montelukast sodium oral granules

MUMBAI, INDIA: Dr Reddy’s Laboratories has launched montelukast sodium oral granules, a bioequivalent generic version of Singulair (montelukast ...

Read more
India Chem 2012, a networking opportunity for Japanese, Indian chemical firms

MUMBAI, INDIA: In recent times, trade between Japan and India is on the rise. A part of the trade is the chemical industry, which presents growth pote ...

Read more
‘Need to create awareness about benefits of the chemical industry’

MUMBAI, INDIA: The chemical industry is now focusing its efforts towards sustainable processes and products. This will be beneficial to the society an ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X